Abstract
Clinicians have limited experience with assessment and treatment of overdose from newer anticonvulsant medications. The aim of this investigation was to evaluate clinical effects of newer anticonvulsant overdose, determine if a relationship exists between dose and clinical effect, and if a particular agent appears more toxic in overdose. This was a retrospective study using electronic poison center data, evaluating clinical outcomes from newer anticonvulsant overdose. The Toxicall™ database from January 1, 2002 to December 31, 2011 was queried using key words: “gabapentin,” “lamotrigine,” “levetiracetam,” “tiagabine,” “topiramate,” “zonisamide,” “pregabalin,” and “oxcarbazine.” Polypharmacy overdose and children less than 15 years of age were excluded. Charts were reviewed by two abstractors for pharmaceutical, self-reported dose, clinical effect score, and clinical signs, symptoms, and vital signs recorded in the chart. Ordinal logistic regression was used to evaluate the relationship between drug type, dose, age, and sex to clinical effect score. Out of 501 cases identified, 347 met the final inclusion criteria. There were 116 gabapentin, 67 lamotrigine, 15 levetiracetam, 15 tiagabine, 56 topiramate, 23 pregabalin, and 55 oxcarbazepine cases. Overdose of newer anticonvulsants frequently results in altered mental status. Seizures may be more common with tiagabine, lamotrigine, and oxcarbazepine. There was one death reported from intentional overdose of topiramate. An information index was created to rank drug toxicity based on reported signs and symptoms for each overdose. There was no significant effect of dose on severity of outcome (β = 0.12, p = 0.23). However, the risk of a more severe outcome score was significantly increased with tiagabine relative to other drugs (β = 2.8, p = 0.001). Lamotrigine ranked highest in terms of toxicity (HT = 1.66) and number of interventions performed (HI = 1.17), and levetiracetam the lowest (HT = 0.98; HI = 0.88). We could not identify a dose-effect in these data which likely reflects the limitations of self-reported doses. Despite limitations of these data, the risk of more severe outcome scores appear to be higher with tiagabine overdose while lamotrigine overdose appears to result in more reported signs, symptoms, and interventions.
Similar content being viewed by others
References
Allison, P. D., & Safari books online. (2012). Logistic regression using SAS (2nd ed.). Cary, NC: SAS Pub
Anand JS, Chodorowski Z, Wisniewski M (2007) Seizures induced by topiramate overdose. Clin Toxicol (Phila) 45(2):197
Awaad Y (2007) Accidental overdosage of levetiracetam in two children caused no side effects. Epilepsy Behav 11(2):247
Barrueto F Jr, Williams K, Howland MA, Hoffman RS, Nelson LS (2002) A case of levetiracetam (keppra) poisoning with clinical and toxicokinetic data. J Toxicol Clin Toxicol 40(7):881–884
Bauer J, Cooper-Mahkorn D (2008) Tiagabine: efficacy and safety in partial seizures—current status. Neuropsychiatr Dis Treat 4(4):731–736
Bodmer M, Monte AA, Kokko J, Yin S (2011) Safety of non-therapeutic levetiracetam ingestions—a poison center based study. Pharmacoepidemiol Drug Saf 20(4):366–369. doi:10.1002/pds.2113
Braga AJ, Chidley K (2007) Self-poisoning with lamotrigine and pregabalin. Anaesthesia 62(5):524–527
Brar B, Glazer JP, Franco K, Edwards T (2005) Acute mental status changes with topiramate. J Am Acad Child Adolesc Psychiatry 44(8):725
Briassoulis G, Kalabalikis P, Tamiolaki M, Hatzis T (1998) Lamotrigine childhood overdose. Pediatr Neurol 19(3):239–242
Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC (2012) 2011 annual report of the american association of poison control centers' national poison data system (NPDS): 29th annual report. Clin Toxicol (Phila, Pa) 50(10):911–1164. doi:10.3109/15563650.2012.746424
Buckley NA, Whyte IM, Dawson AH (1993) Self-poisoning with lamotrigine. Lancet 342(8886–8887):1552–1553
Chung AM, Reed MD (2004) Intentional topiramate ingestion in an adolescent female. Ann Pharmacother 38(9):1439–1442
Dinnerstein E, Jobst BC, Williamson PD (2007) Lamotrigine intoxication provoking status epilepticus in an adult with localization-related epilepsy. Arch Neurol 64(9):1344–1346
Fleurat M, Smollin C (2012) Case files of the University of California San Francisco medical toxicology fellowship: lamotrigine toxicity. J Med Toxicol: Off J Am Coll Med Toxicol 8(1):52–58. doi:10.1007/s13181-012-0210-x
Herold TJ (2006) Lamotrigine as a possible cause of QRS prolongation in a patient with known seizure disorder. Cjem 8(5):361–364
Jette N, Cappell J, VanPassel L, Akman CI (2006) Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy. Neurology 67(8):1514–1515
Jones H, Aguila E, Farber HW (2002) Gabapentin toxicity requiring intubation in a patient receiving long-term hemodialysis. Ann Intern Med 137(1):74
Klein-Schwartz W, Shepherd JG, Gorman S, Dahl B (2003) Characterization of gabapentin overdose using a poison center case series. J Toxicol Clin Toxicol 41(1):11–15
Larson DA (1992) Analysis of variance with just summary statistics as input. Am Stat 46(2):151–152. doi:10.1080/00031305.1992.10475872
Lin G, Lawrence R (2006) Pediatric case report of topiramate toxicity. Clin Toxicol (Phila) 44(1):67–69
Lofton AL, Klein-Schwartz W (2004) Evaluation of lamotrigine toxicity reported to poison centers. Ann Pharmacother 38(11):1811–1815
Lofton AL, Klein-Schwartz W (2005) Evaluation of toxicity of topiramate exposures reported to poison centers. Hum Exp Toxicol 24(11):591–595
Magurran AE (1988) Ecological diversity and its measurement. Princeton University Press; Croom Helm, Princeton
O'Donnell J, Bateman DN (2000) Lamotrigine overdose in an adult. J Toxicol Clin Toxicol 38(6):659–660
Ostrovskiy D, Spanaki MV, Morris GL 3rd (2002) Tiagabine overdose can induce convulsive status epilepticus. Epilepsia 43(7):773–774
Reimers A, Reinholt G (2007) Acute lamotrigine overdose in an adolescent. Ther Drug Monit 29(5):669–670
Schwartz MD, Geller RJ (2007) Seizures and altered mental status after lamotrigine overdose. Ther Drug Monit 29(6):843–844
Thundiyil JG, Kearney TE, Olson KR (2007) Evolving epidemiology of drug-induced seizures reported to a poison control center system. J Med Toxicol 3(1):15–19
Verma A, St Clair EW, Radtke RA (1999) A case of sustained massive gabapentin overdose without serious side effects. Ther Drug Monit 21(6):615–617
Wade JF, Dang CV, Nelson L, Wasserberger J (2010) Emergent complications of the newer anticonvulsants. J Emerg Med 38(2):231–237. doi:10.1016/j.jemermed.2008.03.032
Wax PM, Kleinschmidt KC, Brent J, ACMT ToxIC case registry investigators (2011) The toxicology investigators consortium (ToxIC) registry. J Med Toxicol: Off J Am Coll Med Toxicol 7(4):259–265. doi:10.1007/s13181-011-0177-z
Wisniewski M, Lukasik-Glebocka M, Anand JS (2009) Acute topiramate overdose—clinical manifestations. Clin Toxicol (Phila) 47(4):317–320
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wills, B., Reynolds, P., Chu, E. et al. Clinical Outcomes in Newer Anticonvulsant Overdose: A Poison Center Observational Study. J. Med. Toxicol. 10, 254–260 (2014). https://doi.org/10.1007/s13181-014-0384-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-014-0384-5